Dialysis patients may get to eat fruits again: new diet focuses on hidden potassium

NCT ID NCT06120608

Ongoing Disease control Sponsor: Centre Integre Universitaire de Sante et Services Sociaux du Nord de l'ile de Montreal Source: ClinicalTrials.gov ↗

First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This pilot study tests a new diet for people on hemodialysis who have high potassium levels. Instead of cutting out all high-potassium foods like fruits and vegetables, the diet focuses on avoiding foods with potassium that is easily absorbed, such as additives, processed meats, milk, and fruit juices. The study will see if this approach is practical and helps control potassium levels over 3 months.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: dietary approach (restricting high-bioavailability potassium foods)
What this could lead to: If it works, this could offer a more flexible diet for dialysis patients to manage potassium levels without giving up fruits and vegetables.
What could go wrong: This is a small pilot study with only 50 participants, so results may not apply to everyone. The diet change may be hard to follow or may not lower potassium enough.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for END-STAGE RENAL DISEASE ON HEMODIALYSIS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

end stage renal failure Hyperkalemia pseudohypoaldosteronism type 2

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

HYPERKALEMIA, DIMINISHED RENAL EXCRETION

Contacts and locations

Locations

CIUSSS du Nord-de-l'Île-de-Montréal

Montreal, Quebec, H4J 1C5, Canada

More trials for these conditions

Other studies related to the condition(s) this trial covers.